ArticleThe journal of physical chemistry letters2021
Two-Step Aging of Highly Polar Glass.
Article in The journal of physical chemistry letters, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- New Insights from Nonequilibrium Kinetics Studies on Highly PolarThe journal of physical chemistry letters · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nonequilibrium processes, including physical aging, belong to the most challenging phenomena of glassy dynamics. One of the fundamental problems that needs clarification is the effect of material polarity on the time scale of the structural recovery of glass. The importance of this issue arises from practical applications and recent findings suggesting a substantial contribution of dipole-dipole interactions to the dielectric permittivity spectra of polar glass-formers. Herein, we use dielectric spectroscopy to investigate structural relaxation and aging dynamics of highly polar glass-former 4-[(4,4,5,5,5-pentafluoropentoxy)methyl]-1,3-dioxolan-2-one (FPC), a derivative of propylene carbonate with ε
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.